Kegg medicus dgroup
| DG01449 | |
| DG番号 | DG01449 |
| 分類 | DGroup |
| 名称 | alpha2-Adrenergic receptor agonist TYPE Target |
| ステム | - |
| 構造式 |  |
| メンバー | DG00926 Dexmedetomidine D00514 Dexmedetomidine (USAN/INN) D01205 Dexmedetomidine hydrochloride (JAN/USP) DG01001 Lofexidine D08141 Lofexidine (INN) D04765 Lofexidine hydrochloride (USAN) DG00248 Methyldopa (levorotatory) D08205 Methyldopa (INN) D00405 Methyldopa (USP); Methyldopa hydrate (JP18) DG00249 Clonidine D00281 Clonidine (JAN/USP/INN) D00604 Clonidine hydrochloride (JP18/USP) DG00250 Guanfacine D08031 Guanfacine (INN) D00606 Guanfacine hydrochloride (JAN/USP) DG00442 Brimonidine D07540 Brimonidine (INN) D02076 Brimonidine tartrate (JAN/USAN) DG00773 Tizanidine D08611 Tizanidine (INN) D00776 Tizanidine hydrochloride (JP18/USP) DG01130 Apraclonidine D07461 Apraclonidine (INN) D01008 Apraclonidine hydrochloride (JAN/USP) DG01318 Detomidine D07795 Detomidine (INN) D03702 Detomidine hydrochloride (USAN) DG01320 Medetomidine D08165 Medetomidine (INN) D04883 Medetomidine hydrochloride (USAN) DG01321 Xylazine D08683 Xylazine (USP/INN) D06344 Xylazine hydrochloride (USP) D02388 Levonordefrin (USP); Corbadrine (INN) D08487 Romifidine (INN) |
| 上位グループ | Cardiovascular agent DG01456 Adrenergic receptor agonist DG01450 alpha-Adrenergic receptor agonist |
| 注釈1 | - |
| 注釈2 | - |